In addition to the indication for PSA persistence after radical prostatectomy or PSA relapse without image morphological correlate, a 68Ga-PSMA-PET can also be advantageous for radiation treatment planning in primary PC. This evidence concerns the gene FOLH1 and pachyonychia congenita.